Thyrotoxicosis with diffuse goitre (Q39768): Difference between revisions

← Older edit

@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+E05.0
@@ Property / Linked ICD 10: E05.0 / rank @@
+Normal rank

Latest revision as of 05:18, 13 August 2026

Thyrotoxicosis with diffuse goitre (also known as Graves disease or Basedow disease) is a form of autoimmune thyroid disease and is the leading cause of hyperthyroidism and thyrotoxicosis. In this condition, thyroid-stimulating immunoglobulins bind to and activate the TSH receptor, resulting in excessive thyroid hormone production. The disease is characterized by goiter, rapid and irregular heartbeat, weight loss, irritability, anxiety, and often a (slight) protrusion of the eyeballs.

Language	Label	Description	Also known as
default for all languages	5A02.0
English	Thyrotoxicosis with diffuse goitre	Thyrotoxicosis with diffuse goitre (also known as Graves disease or Basedow disease) is a form of autoimmune thyroid disease and is the leading cause of hyperthyroidism and thyrotoxicosis. In this condition, thyroid-stimulating immunoglobulins bind to and activate the TSH receptor, resulting in excessive thyroid hormone production. The disease is characterized by goiter, rapid and irregular heartbeat, weight loss, irritability, anxiety, and often a (slight) protrusion of the eyeballs.